Cargando…

Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Harimoto, Hirotomo, Shimizu, Masumi, Nakagawa, Yohko, Nakatsuka, Katsuhisa, Wakabayashi, Ayako, Sakamoto, Choitsu, Takahashi, Hidemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026965/ http://dx.doi.org/10.1038/icb.2013.82

Ejemplares similares

Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells
por: Harimoto, Hirotomo, et al.
Publicado: (2013)

Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells
por: Moriya, Keiichi, et al.
Publicado: (2010)

Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression
por: Masu, Takushi, et al.
Publicado: (2018)

HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA
por: Wakabayashi, Ayako, et al.
Publicado: (2018)

Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
por: Liu, Zhiyi, et al.
Publicado: (2014)

Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
por: Huang, Yukun, et al.
Publicado: (2020)

Lymphocyte-polarized DC1s: Effective inducers of tumor-specific CTLs
por: Berk, Erik, et al.
Publicado: (2012)

Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs
por: Bánki, Zoltán, et al.
Publicado: (2010)

Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)

Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides
por: Nakata, Jun, et al.
Publicado: (2018)

Celiac CTLs change their stripes
por: Van Epps, Heather L.
Publicado: (2006)

CTLs: Killers of intracellular bacteria
por: Tian, Li, et al.
Publicado: (2022)

Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013)

Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver
por: Liu, Lei, et al.
Publicado: (2021)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2011)

Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2012)

Tolerogenic and Activatory Plasmacytoid Dendritic Cells in Autoimmunity
por: Guéry, Leslie, et al.
Publicado: (2013)

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications
por: Yoo, Seungbo, et al.
Publicado: (2016)

Metabolism Is Central to Tolerogenic Dendritic Cell Function
por: Sim, Wen Jing, et al.
Publicado: (2016)

Ethyl Pyruvate Induces Tolerogenic Dendritic Cells
por: Djedovic, Neda, et al.
Publicado: (2019)

Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
por: Passeri, Laura, et al.
Publicado: (2021)

Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
por: Nam, Ji-Hee, et al.
Publicado: (2021)

The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
por: Seliger, Barbara, et al.
Publicado: (2013)

Induction of tumor-specific CD8(+) cytotoxic T lymphocytes from naïve human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells
por: Tomita, Yuji, et al.
Publicado: (2019)

Cell therapy using tolerogenic dendritic cells in transplantation
por: Moreau, Aurélie, et al.
Publicado: (2012)

Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man
por: Raker, Verena K., et al.
Publicado: (2015)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update
por: Švajger, Urban, et al.
Publicado: (2018)

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)

Vpx-containing Dendritic Cell Vaccine Vectors Induce CTLs and Reactivate Latent HIV-1 in vitro
por: Norton, Thomas D., et al.
Publicado: (2015)

Japanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8(+) T cells
por: Takaku, Shun, et al.
Publicado: (2017)

Comparative study of clinical grade human tolerogenic dendritic cells
por: Naranjo-Gómez, M, et al.
Publicado: (2011)

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
por: Harry, Rachel A, et al.
Publicado: (2010)

Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
por: Hubo, Mario, et al.
Publicado: (2013)

The nature of activatory and tolerogenic dendritic cell-derived signal II
por: Bakdash, Ghaith, et al.
Publicado: (2013)

The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2
por: Granucci, Francesca, et al.
Publicado: (2014)

MicroRNA Profiling of Activated and Tolerogenic Human Dendritic Cells
por: Stumpfova, Zuzana, et al.
Publicado: (2014)

The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2
por: Granucci, Francesca, et al.
Publicado: (2013)

Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
por: Xie, Zhong-Xiang, et al.
Publicado: (2015)

Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone
por: Lee, Jae-Hee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tuta8c328b9penpmvkqk3uj0an